These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11005750)

  • 1. Fibrogenesis. IV. Fibrosis and inflammatory bowel disease: cellular mediators and animal models.
    Pucilowska JB; Williams KL; Lund PK
    Am J Physiol Gastrointest Liver Physiol; 2000 Oct; 279(4):G653-9. PubMed ID: 11005750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severity of local inflammation does not impact development of fibrosis in mouse models of intestinal fibrosis.
    Hünerwadel A; Fagagnini S; Rogler G; Lutz C; Jaeger SU; Mamie C; Weder B; Ruiz PA; Hausmann M
    Sci Rep; 2018 Oct; 8(1):15182. PubMed ID: 30315190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease.
    Lovisa S; Genovese G; Danese S
    J Crohns Colitis; 2019 Apr; 13(5):659-668. PubMed ID: 30520951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic modulation during intestinal fibrosis.
    Bos S; Laukens D
    J Dig Dis; 2020 Jun; 21(6):319-325. PubMed ID: 32406133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversial Contribution of Th17/IL-17 Toward the Immune Response in Intestinal Fibrosis.
    Latella G; Viscido A
    Dig Dis Sci; 2020 May; 65(5):1299-1306. PubMed ID: 32124197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic aspects and therapeutic avenues of intestinal fibrosis in Crohn's disease.
    Zorzi F; Calabrese E; Monteleone G
    Clin Sci (Lond); 2015 Dec; 129(12):1107-13. PubMed ID: 26494636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-beta1 gene transfer to the mouse colon leads to intestinal fibrosis.
    Vallance BA; Gunawan MI; Hewlett B; Bercik P; Van Kampen C; Galeazzi F; Sime PJ; Gauldie J; Collins SM
    Am J Physiol Gastrointest Liver Physiol; 2005 Jul; 289(1):G116-28. PubMed ID: 15778431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elafin Reverses Intestinal Fibrosis by Inhibiting Cathepsin S-Mediated Protease-Activated Receptor 2.
    Xie Y; Fontenot L; Chupina Estrada A; Nelson B; Wang J; Shih DQ; Ho W; Mattai SA; Rieder F; Jensen DD; Bunnett NW; Koon HW
    Cell Mol Gastroenterol Hepatol; 2022; 14(4):841-876. PubMed ID: 35840034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral pirfenidone protects against fibrosis by inhibiting fibroblast proliferation and TGF-β signaling in a murine colitis model.
    Li G; Ren J; Hu Q; Deng Y; Chen G; Guo K; Li R; Li Y; Wu L; Wang G; Gu G; Li J
    Biochem Pharmacol; 2016 Oct; 117():57-67. PubMed ID: 27498142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of tissue remodeling in inflammatory bowel disease.
    Rieder F; Fiocchi C
    Dig Dis; 2013; 31(2):186-93. PubMed ID: 24030223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of noncontrast MRI magnetization transfer and T2 -Weighted signal intensity ratios for detection of bowel wall fibrosis in a Crohn's disease animal model.
    Dillman JR; Swanson SD; Johnson LA; Moons DS; Adler J; Stidham RW; Higgins PD
    J Magn Reson Imaging; 2015 Sep; 42(3):801-10. PubMed ID: 25504823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological Regulation of Intestinal Fibrosis in Inflammatory Bowel Disease.
    Bamias G; Pizarro TT; Cominelli F
    Inflamm Bowel Dis; 2022 Mar; 28(3):337-349. PubMed ID: 34904152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can we influence fibrosis in Crohn's disease?
    Assche GV
    Acta Gastroenterol Belg; 2001; 64(2):193-6. PubMed ID: 11475134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of Nuclear Receptor Nur77 Aggravates Mouse Experimental Colitis by Increased NFκB Activity in Macrophages.
    Hamers AA; van Dam L; Teixeira Duarte JM; Vos M; Marinković G; van Tiel CM; Meijer SL; van Stalborch AM; Huveneers S; Te Velde AA; de Jonge WJ; de Vries CJ
    PLoS One; 2015; 10(8):e0133598. PubMed ID: 26241646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of experimental mouse models of inflammatory bowel disease.
    Oh SY; Cho KA; Kang JL; Kim KH; Woo SY
    Int J Mol Med; 2014 Feb; 33(2):333-40. PubMed ID: 24285285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin.
    Mathur R; Alam MM; Zhao XF; Huang Y; Zhu X
    J Vis Exp; 2019 Sep; (151):. PubMed ID: 31566603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E₂ and polyenylphosphatidylcholine protect against intestinal fibrosis and regulate myofibroblast function.
    Baird AC; Lloyd F; Lawrance IC
    Dig Dis Sci; 2015 Jun; 60(6):1603-16. PubMed ID: 25630423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective and aggravating effects of Nlrp3 inflammasome activation in IBD models: influence of genetic and environmental factors.
    Bauer C; Duewell P; Lehr HA; Endres S; Schnurr M
    Dig Dis; 2012; 30 Suppl 1():82-90. PubMed ID: 23075874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Oxysterol Synthesising Enzyme CH25H Contributes to the Development of Intestinal Fibrosis.
    Raselli T; Wyss A; Gonzalez Alvarado MN; Weder B; Mamie C; Spalinger MR; Van Haaften WT; Dijkstra G; Sailer AW; Imenez Silva PH; Wagner CA; Tosevski V; Leibl S; Scharl M; Rogler G; Hausmann M; Misselwitz B
    J Crohns Colitis; 2019 Sep; 13(9):1186-1200. PubMed ID: 31220227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of Intestinal Fibrosis in Inflammatory Bowel Disease and Perspectives for Therapeutic Implication.
    Bettenworth D; Rieder F
    Dig Dis; 2017; 35(1-2):25-31. PubMed ID: 28147352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.